• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞膜包覆的人发纳米颗粒用于精准疾病治疗。

Cell membrane-coated human hair nanoparticles for precise disease therapies.

机构信息

Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, 310016, China.

Department of Breast Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, China.

出版信息

J Nanobiotechnology. 2022 Nov 16;20(1):480. doi: 10.1186/s12951-022-01673-6.

DOI:10.1186/s12951-022-01673-6
PMID:36384635
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9670514/
Abstract

Precision medicine is the ultimate goal for current disease therapies, including tumor and infection. The lack of specific targeted drugs for liver cancer and the lack of specific anti-infective drugs in the treatment of diabetic foot ulcer with infection (DFI) are the representative obstacles in those 2 major diseases currently plaguing human beings. Inventing natural biocompatible polymers derived from natural materials is one of the main development directions of current bio-medical materials. Though previous studies have demonstrated the potential application values of human black hair-derived nanoparticles (HNP) in cancer, methicillin-resistant Staphylococcus aureus (MRSA) infection, and thrombosis scenarios treatments, it still has not solved the problem of low local therapeutic concentration and general targeting ability. Here, we firstly modified the HNP with membrane encapsulations, which endowed these dual-pure natural bio-fabricated materials with better targeting ability at the disease sites with no reduction in photothermal therapy (PTT) effect. HNP coated by red blood cell membrane loaded with DSPE-PEG-cRGD peptide for the therapeutic application of liver cancer greatly prolonged in vivo circulation time and enhanced local targeting efficacy as well as low toxicity; HNP coated by the murine macrophage cell membrane (RAWM) for the DFIs treatment greatly promoted the adhesive ability of HNP on the bacteria and thereby improved the killing effect. Briefly, the appropriate cell membranes camouflaged HNP nanomedicine has the characteristics of excellent photothermal effect, an all-natural source with excellent biocompatibility and easy access, which is expected to have huge potential in both benign and malignant diseases.

摘要

精准医学是当前疾病治疗的终极目标,包括肿瘤和感染。肝癌缺乏特异性靶向药物,糖尿病足溃疡伴感染(DFI)治疗缺乏特异性抗感染药物,是目前困扰人类的两大疾病的代表性障碍。发明源自天然材料的天然生物相容性聚合物是当前生物医学材料的主要发展方向之一。尽管先前的研究已经证明了人发衍生纳米颗粒(HNP)在癌症、耐甲氧西林金黄色葡萄球菌(MRSA)感染和血栓形成情况下治疗的潜在应用价值,但仍未解决局部治疗浓度低和普遍靶向能力差的问题。在这里,我们首先用膜包裹 HNP,使这些双重纯净的天然生物制造材料在疾病部位具有更好的靶向能力,而不会降低光热治疗(PTT)效果。用载有 DSPE-PEG-cRGD 肽的红细胞膜包裹 HNP 用于肝癌治疗,大大延长了体内循环时间,增强了局部靶向疗效,且毒性低;用鼠巨噬细胞膜(RAWM)包裹 HNP 用于 DFI 治疗,大大提高了 HNP 对细菌的粘附能力,从而提高了杀菌效果。简而言之,适当的细胞膜伪装 HNP 纳米医学具有优异的光热效应、全天然来源、优异的生物相容性和易于获取的特点,有望在良性和恶性疾病中具有巨大的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ab/9670514/e96fd82b8e5c/12951_2022_1673_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ab/9670514/d2c592b34048/12951_2022_1673_Sch1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ab/9670514/99e1d2d836bd/12951_2022_1673_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ab/9670514/e9353f0d1a64/12951_2022_1673_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ab/9670514/049c5dd4bc96/12951_2022_1673_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ab/9670514/8fe3b4026cdb/12951_2022_1673_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ab/9670514/2800914ab66b/12951_2022_1673_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ab/9670514/e96fd82b8e5c/12951_2022_1673_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ab/9670514/d2c592b34048/12951_2022_1673_Sch1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ab/9670514/99e1d2d836bd/12951_2022_1673_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ab/9670514/e9353f0d1a64/12951_2022_1673_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ab/9670514/049c5dd4bc96/12951_2022_1673_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ab/9670514/8fe3b4026cdb/12951_2022_1673_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ab/9670514/2800914ab66b/12951_2022_1673_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ab/9670514/e96fd82b8e5c/12951_2022_1673_Fig6_HTML.jpg

相似文献

1
Cell membrane-coated human hair nanoparticles for precise disease therapies.细胞膜包覆的人发纳米颗粒用于精准疾病治疗。
J Nanobiotechnology. 2022 Nov 16;20(1):480. doi: 10.1186/s12951-022-01673-6.
2
Red blood cell membrane-camouflaged melanin nanoparticles for enhanced photothermal therapy.红细胞膜伪装的黑色素纳米颗粒用于增强光热治疗。
Biomaterials. 2017 Oct;143:29-45. doi: 10.1016/j.biomaterials.2017.07.027. Epub 2017 Jul 20.
3
In vivo photothermal inhibition of methicillin-resistant Staphylococcus aureus infection by in situ templated formulation of pathogen-targeting phototheranostics.原位模板法构建靶向诊疗一体化载药系统抑制耐甲氧西林金黄色葡萄球菌感染的活体光热治疗
Nanoscale. 2020 Apr 14;12(14):7651-7659. doi: 10.1039/d0nr00181c. Epub 2020 Mar 24.
4
Erythrocyte-Cancer Hybrid Membrane Camouflaged Hollow Copper Sulfide Nanoparticles for Prolonged Circulation Life and Homotypic-Targeting Photothermal/Chemotherapy of Melanoma.红细胞-癌细胞杂化膜伪装的中空硫化铜纳米粒子用于延长循环寿命和黑色素瘤的同型靶向光热/化疗。
ACS Nano. 2018 Jun 26;12(6):5241-5252. doi: 10.1021/acsnano.7b08355. Epub 2018 May 30.
5
Erythrocyte-cancer hybrid membrane-camouflaged melanin nanoparticles for enhancing photothermal therapy efficacy in tumors.红细胞-癌细胞杂化膜伪装黑色素纳米颗粒增强肿瘤光热治疗效果。
Biomaterials. 2019 Feb;192:292-308. doi: 10.1016/j.biomaterials.2018.11.021. Epub 2018 Nov 15.
6
Effect of antimicrobial peptides HNP-1 and hBD-1 on Staphylococcus aureus strains in vitro and in vivo.抗菌肽 HNP-1 和 hBD-1 对金黄色葡萄球菌体外和体内菌株的影响。
Fundam Clin Pharmacol. 2020 Feb;34(1):102-108. doi: 10.1111/fcp.12499. Epub 2019 Aug 5.
7
Biodegradable zwitterionic polymer membrane coating endowing nanoparticles with ultra-long circulation and enhanced tumor photothermal therapy.可生物降解的两性离子聚合物膜包覆赋予纳米颗粒超长循环能力并增强肿瘤光热治疗效果。
Biomaterials. 2020 Feb;231:119680. doi: 10.1016/j.biomaterials.2019.119680. Epub 2019 Dec 13.
8
Oxygen self-enriched nanoparticles functionalized with erythrocyte membranes for long circulation and enhanced phototherapy.用红细胞膜功能化的自富氧纳米颗粒用于长循环和增强光疗。
Acta Biomater. 2017 Sep 1;59:269-282. doi: 10.1016/j.actbio.2017.06.035. Epub 2017 Jun 27.
9
Enhanced photothermal therapy of biomimetic polypyrrole nanoparticles through improving blood flow perfusion.通过改善血流灌注增强仿生聚吡咯纳米颗粒的光热治疗效果。
Biomaterials. 2017 Oct;143:130-141. doi: 10.1016/j.biomaterials.2017.08.004. Epub 2017 Aug 5.
10
Bacteria-Activated Theranostic Nanoprobes against Methicillin-Resistant Staphylococcus aureus Infection.细菌激活的抗耐甲氧西林金黄色葡萄球菌感染治疗诊断一体化纳米探针
ACS Nano. 2017 May 23;11(5):4428-4438. doi: 10.1021/acsnano.7b00041. Epub 2017 Mar 30.

引用本文的文献

1
Thrombolytic therapy of human black hair and Au drug-loaded nanocapsules in vivo and in vitro based on near infrared II laser response.基于近红外II激光响应的人黑发与载金药物纳米胶囊的体内外溶栓治疗
J Mater Sci Mater Med. 2025 Jul 30;36(1):62. doi: 10.1007/s10856-025-06910-6.
2
Biomimetic nanoparticles for targeted therapy of liver disease.用于肝病靶向治疗的仿生纳米颗粒。
RSC Pharm. 2025 Apr 28. doi: 10.1039/d5pm00044k.
3
Cell Membrane-Coated Biomimetic Nanoparticles in Cancer Treatment.用于癌症治疗的细胞膜包被仿生纳米颗粒

本文引用的文献

1
Exploration of Lipid-Based Nanocarriers as Drug Delivery Systems in Diabetic Foot Ulcer.探索载脂纳米载体作为糖尿病足溃疡的药物传递系统。
Mol Pharm. 2022 Jul 4;19(7):1977-1998. doi: 10.1021/acs.molpharmaceut.1c00970. Epub 2022 Apr 28.
2
Guidelines development protocol and findings: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease.指南制定方案和发现:2021 年澳大利亚糖尿病相关足部疾病循证指南的一部分。
J Foot Ankle Res. 2022 Apr 19;15(1):28. doi: 10.1186/s13047-022-00533-8.
3
Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders.
Pharmaceutics. 2024 Apr 12;16(4):531. doi: 10.3390/pharmaceutics16040531.
4
Cell Membrane Biomimetic Nano-Delivery Systems for Cancer Therapy.用于癌症治疗的细胞膜仿生纳米递送系统
Pharmaceutics. 2023 Dec 13;15(12):2770. doi: 10.3390/pharmaceutics15122770.
5
Red blood cells: a potential delivery system.红细胞:一种有潜力的药物递送系统。
J Nanobiotechnology. 2023 Aug 22;21(1):288. doi: 10.1186/s12951-023-02060-5.
利用自然杀伤细胞进行癌症免疫治疗:派遣第一响应者。
Nat Rev Drug Discov. 2022 Aug;21(8):559-577. doi: 10.1038/s41573-022-00413-7. Epub 2022 Mar 21.
4
The changing role of natural killer cells in cancer metastasis.自然杀伤细胞在癌症转移中的作用变化。
J Clin Invest. 2022 Mar 15;132(6). doi: 10.1172/JCI143762.
5
The Promising Hydrogel Candidates for Preclinically Treating Diabetic Foot Ulcer: A Systematic Review and Meta-Analysis.具有临床治疗糖尿病足溃疡前景的水凝胶候选物:系统评价和荟萃分析。
Adv Wound Care (New Rochelle). 2023 Jan;12(1):28-37. doi: 10.1089/wound.2021.0162. Epub 2022 Apr 11.
6
Ruthenium complexes boost NK cell immunotherapy via sensitizing triple-negative breast cancer and shaping immuno-microenvironment.钌配合物通过增强三阴性乳腺癌的敏感性和塑造免疫微环境来增强自然杀伤细胞免疫疗法。
Biomaterials. 2022 Feb;281:121371. doi: 10.1016/j.biomaterials.2022.121371. Epub 2022 Jan 11.
7
The role of gel wound dressings loaded with stem cells in the treatment of diabetic foot ulcers.负载干细胞的凝胶伤口敷料在糖尿病足溃疡治疗中的作用。
Am J Transl Res. 2021 Dec 15;13(12):13261-13272. eCollection 2021.
8
Novel therapeutic targets for diabetes-related wounds or ulcers: an update on preclinical and clinical research.糖尿病相关伤口或溃疡的新型治疗靶点:临床前和临床研究的最新进展。
Expert Opin Ther Targets. 2021 Dec;25(12):1061-1075. doi: 10.1080/14728222.2021.2014816. Epub 2021 Dec 22.
9
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 3: PD-L1, Intracellular Signaling Pathways and Tumor Microenvironment.我们需要了解前列腺癌中 PD-L1 表达的哪些信息?系统文献回顾。第 3 部分:PD-L1、细胞内信号通路和肿瘤微环境。
Int J Mol Sci. 2021 Nov 15;22(22):12330. doi: 10.3390/ijms222212330.
10
Perforin, COVID-19 and a possible pathogenic auto-inflammatory feedback loop.穿孔素、COVID-19 与可能存在的致病自身炎症性反馈回路。
Scand J Immunol. 2021 Nov;94(5):e13102. doi: 10.1111/sji.13102. Epub 2021 Sep 22.